AZD9833 with capivasertib clinical trials

Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.

This study is looking into a new medicine, AZD9833, for women with advanced breast cancer that is hormone-sensitive (ER+) but not HER2-positive. It's testing AZD9833 alone or with other common cancer drugs to see if it's safe and how well it works.